(Reuters) -The U.S. Food and Drug Administration on Friday approved an Amgen Inc drug for lung cancer patients with a specific mutation in a gene known as KRAS
Coronavirus vaccine is 94.5% effective: Moderna Moderna announces vaccine trials show high effectiveness; reaction from Gov. Tate Reeves on ‘Fox & Friends.’ Moderna on Wednesday announced that the
WEDNESDAY, Oct. 7, 2020 — Eli Lilly and Co. is seeking U.S. approval for emergency use of an experimental antibody therapy for COVID-19. The request to the U.S.
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok